Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aradigm

Aradigm
1991 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
ARDMQ STOCK SYMBOL
$0.04 SHARE PRICE (As of Friday Closing)
Description

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Stock Exchange
PINX
Primary Office
  • 3929 Point Eden Way
  • Hayward, CA 94545
  • United States

+1 (510) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aradigm’s full profile, request a free trial.

Aradigm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.02 - $0.20 $578K $0.02 21.7K

Aradigm Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 36,099 103,436 8,229 18,772
Revenue 4,380 14,465 195 23,429
EBITDA (12,169) (6,809) (30,499) (17,035)
Net Income (16,416) (10,705) (32,938) (17,209)
Total Assets 3,758 8,065 25,054 35,626
Total Debt 24,309 15,008 13,219 104
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aradigm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aradigm‘s full profile, request access.

Request full access to PitchBook

Aradigm Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verona Pharma Corporation London, United Kingdom 00 000.00 000000000 000.00
000-000 Corporate Backed or Acquired Vienna, VA 00 0000 000000000 0000
00000000 000000000 Formerly VC-backed Lake Forest, IL 000 00000 000000 - 000 00000
000000 00000000000 Venture Capital-Backed Carlsbad, CA 0 000.00 00000000000 000.00
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Aradigm Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aradigm‘s full profile, request access.

Request full access to PitchBook

Aradigm Executive Team (12)

Name Title Board
Seat
Contact
Info
James Blanchard Principal Scientist

11 Former Executives

You’re viewing 1 of 12 executives. Get the full list »

Aradigm Board Members (5)

Name Representing Role Since Contact
Info
00000 0000 Grifols Board Member 000 0000

4 Former Board Members

You’re viewing 1 of 5 board members. Get the full list »